Year None20262025202420232022202120202019 Jun 05, 2026 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 03, 2026 New Expert Consensus Provides Age-Specific Guidance for Improving Care for Individuals with Genital May 26, 2026 Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference May 08, 2026 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 06, 2026 Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update Apr 27, 2026 Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% t Apr 22, 2026 Arcutis’ ZORYVE® (roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatolo Apr 15, 2026 Arcutis to Report First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026 Mar 31, 2026 Arcutis Management to Present at the 25th Annual Needham Virtual Healthcare Conference Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 9 of 23